Summary. Primatene Mist inhalers provide temporary relief from mild, intermittent asthma symptoms. They are the only OTC asthma inhaler approved by the FDA to relieve asthma symptoms like wheezing ...

Primatene Mist was appealing to many asthma sufferers because it didn't require a prescription. But Wednesday's move to allow the inhaler to return to store shelves has also been met with ...

A new version of the asthma inhaler Primatene Mist will soon be in U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler Wednesday for temporary relief of ...

Primatene Mist, a once popular OTC asthma inhaler, can go back on the market again, the FDA says. It's now made with an environmentally friendly propellent.

Primatene Mist is an inhaler that uses the active ingredient epinephrine. During an asthma attack, it opens the airways and allows the user to breathe.

Set to be banned outright by the Food and Drug Administration next year, Primatene Mist has already become scarce because of a shortage of a material used to make it.

Asthmatics who rely on Primatene Mist to control their symptoms need to start stocking up on the over-the-counter medicine now -- or find a new prescription alternative. The FDA reminded us today ...

Primatene MIST (epinephrine inhalation aerosol bronchodilator suspension; Amphastar) is now available over-the-counter (OTC) for the temporary relief of mild symptoms of intermittent asthma (eg ...

Primatene Mist uses CFCs as a propellant to move the medicine out of the inhaler and into the lungs. The FDA is concerned about whether the word has gotten out to people who use Primatene Mist.

An attempt to protect the ozone layer has effectively removed the only over-the-counter asthma inhaler from the market, forcing some asthma sufferers to find room in their budgets for visits ...